Your heart, your health, your control.
Our goal
Measure ECG’s everywhere, anytime
At HeartEye, we’re transforming personal healthcare with our revolutionary handheld ECG device. Designed for ease of use and portability, our device puts the power of clinical grade heart health monitoring right in your hands. Whether at home, at work, or on the go, our cutting-edge technology provides accurate, real-time insights, helping you stay informed and in control. No more waiting for appointments or relying on bulky equipment – experience peace of mind with a device that fits your life.
Our mission
Affordable, accurate, and accessible
heart health for everyone
At HeartEye, we believe that everyone deserves easy access to reliable heart health monitoring. Our mission is to revolutionize the way people track their heart health with an affordable, user-friendly handheld ECG device that works for both healthcare providers and individuals. By combining simplicity, accuracy, and affordability, we’re empowering people everywhere to take control of their heart health—whenever and wherever they need it.
A word from our founders
Why we do what we do
HeartEye was founded by a team of experienced cardiologists who are passionate about improving heart care for everyone. Combining years of clinical expertise with cutting-edge technology, we’ve created a revolutionary handheld ECG device that’s both easy to use and highly accurate. To ensure our product meets the evolving needs of heart healthcare, we’ve partnered with leading software developers and design experts. By combining medical expertise with current technology and design, we’ve developed a solution that empowers individuals and healthcare providers to take control of heart health in the most effective way possible.
HeartEye’s core team brings a wealth of experience and expertise crucial for the successful development and commercialization of the ECG device. This team has successfully patented the technology and established the HeartEye app and data platform, positioning the company for final clinical validation, regulatory approvals, and market launch.
Tjebbe Tauber
CEO
Tjebbe Tauber, CEO, has over a decade of experience in business development and innovation within the healthcare sector. His career is marked by significant contributions to the development of medical innovations aimed at enhancing patient care and improving health outcomes. Tjebbe’s background in consultancy and the financial sector has equipped him with the skills necessary to navigate the complexities of medical device commercialization, from securing funding to managing regulatory approvals. Under his leadership, HeartEye aims to revolutionize cardiac diagnostics with the mini-ECG, leveraging his extensive network and strategic vision to drive the company toward its goal of becoming a market leader in portable ECG technology.
Rien van der Zee
CMO | Co-Founder
Dr. Rien van der Zee, CMO and co-founder, holds a PhD in physiology and is a highly experienced cardiologist with over 30 years of expertise in the field. He is a leading expert in product development and has authored the patent for HeartEye’s ECG. His profound knowledge and extensive experience in cardiology and medical innovation significantly contribute to HeartEye’s mission of advancing cardiac care through cutting-edge technology. He serves as the chairman of the Cardiovascular Biology Foundation, focusing on preclinical diagnosis of heart disease to reduce out-of-hospital mortality. Dr. van der Zee has conducted extensive research on cell physiology in the vascular wall in Maastricht and Boston, aiming to predict and prevent acute coronary events that can lead to sudden death. His foundation has sponsored and participated in numerous studies on cardiogenetics, fostering connections between healthcare professionals, technical institute spinoffs, and medical companies. This collaborative approach has been instrumental in developing innovative devices for independent cardiac monitoring.
Pieter Doevendans
Chair of the Advisory Board | Co-Founder
Professor Dr. Pieter Doevendans is a distinguished cardiologist with over 30 years of research and clinical experience. With over 800 peer-reviewed papers and 12 books published, Dr. Doevendans is a prolific contributor to the field. As an active member of the European Society of Cardiology and Director of the Netherlands Heart Institute since 2015, he offers invaluable insights into networking and grant applications, significantly enhancing HeartEye’s strategic initiatives. His extensive experience and prominent role in the cardiology community are critical assets to HeartEye’s mission and growth.
Rutger van Merkerk
CTO
Rutger van Merkerk holds a PhD in applied physics as well as in business administration and has extensive experience in strategic planning and regulatory legislation, supporting medical device companies, project management, and engineering design. He has proven excellent in team building, executing quality assurance and compliance, IPR management, and user-centeric medical technology innovations. At Hearteye he oversees the technical implementation, paying attention to both the flawless operation of the device and its ease of use.
Christina Tu
Master’s graduate Information Systems
Master’s graduate in Information Systems with expertise in optimizing interactions between technology, people, and organizations. Skilled in transforming data into actionable insights, communicating complex findings, and bridging technical and operational needs. Experienced in data analysis, dashboard development, and driving innovation in dynamic environments.
At HeartEye, she ensures compliance with worldwide medical device regulations and develops certification schemes, collaborating with diverse stakeholders, balancing technical and business requirements to deliver innovative outcomes.
Our timeline
Achieved milestones and future plans
2018
- First prototype developed & tested by founders
- Patent covering 12-lead ECG registration (patent no. 2021115)
2021
- Development of the research prototype of the recording device, the app, and the platform
- Preliminary tests performed on a patient with acute myocardial infarction
2023
- Validation study in a pre-clinical environment (porcine coronary occlusion model)
2024 – present
- Clinical pilot study performed in an emergency room setting.
- Filed patent covering machine learning algorithm for optimal cardiac triage (patent no. 2037702)
- Development of the production model
Ongoing development:
- Industrialization of the production model (Beta & market version)
Industry partners
Companies & organisations we proudly work with
